Director, Loyalty Marketing
NutrafolSalary not specified
- Full Time
- Senior (5 to 8 years)
About Nutrafol
Nutrafol focuses on improving hair health by providing natural supplements aimed at addressing hair thinning and promoting hair growth. Their products are formulated with a blend of vitamins, minerals, and natural ingredients that target the underlying causes of hair loss, such as genetics, stress, diet, and environmental factors. Nutrafol sells these supplements directly to consumers through their website, offering personalized plans developed by naturopathic doctors to meet individual needs. Unlike many competitors, Nutrafol emphasizes a drug-free approach and backs its products with clinical studies to ensure safety and effectiveness. The company's goal is to help individuals achieve visibly thicker and stronger hair through tailored, data-driven solutions.
New York City, New YorkHeadquarters
2013Year Founded
$34MTotal Funding
SERIES_BCompany Stage
Healthcare, Consumer GoodsIndustries
201-500Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Performance Bonus
Unlimited Paid Time Off
Wellness Program
Meal Benefits
Phone/Internet Stipend
Professional Development Budget
Pet Insurance
Remote Work Options
Risks
Increased competition from new entrants like Divi could impact Nutrafol's market share.
Nutrafol Skin faces challenges in a saturated acne treatment market.
Partnership with Sephora may lead to competition with established brands in their retail space.
Differentiation
Nutrafol offers a whole-body approach to hair health, unlike many competitors.
The company is backed by over 3,000 physicians, clinics, and stylists in the U.S.
Nutrafol's products are clinically proven, drug-free, and target root causes of hair thinning.
Upsides
Nutrafol's expansion into skin health taps into a large, existing market.
Partnership with Sephora increases Nutrafol's visibility and retail presence.
Growing consumer interest in personalized health solutions aligns with Nutrafol's offerings.
Funding
Total raised$34.05 M
Latest valuation$175.00 M
StageSERIES_B
SERIES B
3/31/2019$35
$175.00 M